| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.10. | Merck KGaA's $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer | ||
| 19.10. | With $5M, Phantom GI Plans to Develop Minimally Invasive Alternative Ostomy Surgery Device | ||
| 19.10. | Diagnosis Is Beside the Point | ||
| 18.10. | Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder | ||
| 18.10. | Allswell Raises $7M to Grow LGBTQ+ Behavioral Health Platform | ||
| 18.10. | The Antibiotics Exist -The System Cannot Deliver Them | ||
| 18.10. | Exercise is Prescribed Like Advice When It Should Be Delivered Like Treatment | ||
| 18.10. | UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform | ||
| 16.10. | City Therapeutics' Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver | ||
| 16.10. | The Impending End of Cross-Subsidization | ||
| 16.10. | How AI Is Connecting MedTech's Data Without Compromising Compliance | ||
| 16.10. | Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal | ||
| 15.10. | AI Biotech Iambic Gets $150M in IPO Cash for 'Molecular Superintelligence' Drug R&D | ||
| 15.10. | Why the Future of Healthcare Depends on Reinventing Primary Care Access | ||
| 15.10. | The Role of Hospital Stewardship to Improve Outcomes and Manage Costs | ||
| 15.10. | HealthTap Introduces Virtual Primary Care Program for DME Suppliers | ||
| 14.10. | Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building | ||
| 14.10. | Healthleap Raises $38M to Expand AI Screening for Overlooked Conditions in Hospitalized Patients | ||
| 14.10. | Why Agentic AI Works in Hospitals When You Strip It Down | ||
| 14.10. | Happy Health's Cuffless BP Device Wins FDA Clearance | ||
| 13.10. | Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity | ||
| 13.10. | Medicare Policy Shouldn't Be Made in the Shadows | ||
| 13.10. | What Corporate Venture Funds Get Wrong about Strategic Value | ||
| 12.10. | Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug | ||
| 12.10. | Outro Raises $7M To Support Safe Deprescribing |